BioCapital Europe - Presenting companies announced



BioCapital Europe

BioCapital Europe, Europe's premier life sciences investment conference organised by LSP (Life Sciences Partners) and ABN AMRO, is delighted to announce the presenting companies for its 10th consecutive event on Thursday 19 April 2012 in Amsterdam, The Netherlands.


Presenting Companies



Activaero (GER) Complix (BEL) Merus (NL)
ActoGeniX (BEL) Curetis (GER) OctoPlus (NL) - Public
Affimed Therapeutics (GER) Epigenomics (GER) - Public Pharming (NL) - Public
Agendia (NL) Evotec (GER) - Public Probiodrug (GER)
AIMM Therapeutics (NL) EyeSense (GER) ProFibrix (NL)
Amakem (BEL) Genmab (DK) - Public Pronota (BEL)
AM-Pharma (NL) Hybrigenics (FR) - Public Prosensa (NL)
Arcarios (NL) i-Optics (NL) Sapiens (NL)
arGEN-X (NL) ISA Pharmaceuticals (NL) SuperSonic Imagine (FR)
Atlas Genetics (UK) Kreatech Diagnostics (NL) ThromboGenics (BEL) - Public
Biocartis (BEL/CH) MDxHealth (BEL) - Public TiGenix (BEL) - Public
BioInvent (SWE) - Public Medisse (NL) to-BBB (NL)
BMEYE (NL) Mendor (FIN) Zealand Pharma (DK) - Public

For the second year running, the event will be held at the luxurious and historic hotel Sofitel Amsterdam The Grand, the former town hall situated in the heart of Amsterdam. In 2011, the event attracted 200 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited free of charge to this event. The 2011 conference was a huge success and places filled up quickly, so make sure you register now!

Click here to register today

Registration:
Please visit the BioCapital Europe 2012 website at www.biocapitaleurope.com for online registration. If you require assistance, or have any questions, please do not hesitate to contact Jenna Parker on +44 (0) 20 7250 7043 or email her on wraan.cnexre@ivgrffrzrqvn.pb.hx
« back to overview
Follow us

BioCapital Europe - Presenting companies announced



BioCapital Europe

BioCapital Europe, Europe's premier life sciences investment conference organised by LSP (Life Sciences Partners) and ABN AMRO, is delighted to announce the presenting companies for its 10th consecutive event on Thursday 19 April 2012 in Amsterdam, The Netherlands.


Presenting Companies



Activaero (GER) Complix (BEL) Merus (NL)
ActoGeniX (BEL) Curetis (GER) OctoPlus (NL) - Public
Affimed Therapeutics (GER) Epigenomics (GER) - Public Pharming (NL) - Public
Agendia (NL) Evotec (GER) - Public Probiodrug (GER)
AIMM Therapeutics (NL) EyeSense (GER) ProFibrix (NL)
Amakem (BEL) Genmab (DK) - Public Pronota (BEL)
AM-Pharma (NL) Hybrigenics (FR) - Public Prosensa (NL)
Arcarios (NL) i-Optics (NL) Sapiens (NL)
arGEN-X (NL) ISA Pharmaceuticals (NL) SuperSonic Imagine (FR)
Atlas Genetics (UK) Kreatech Diagnostics (NL) ThromboGenics (BEL) - Public
Biocartis (BEL/CH) MDxHealth (BEL) - Public TiGenix (BEL) - Public
BioInvent (SWE) - Public Medisse (NL) to-BBB (NL)
BMEYE (NL) Mendor (FIN) Zealand Pharma (DK) - Public

For the second year running, the event will be held at the luxurious and historic hotel Sofitel Amsterdam The Grand, the former town hall situated in the heart of Amsterdam. In 2011, the event attracted 200 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited free of charge to this event. The 2011 conference was a huge success and places filled up quickly, so make sure you register now!

Click here to register today

Registration:
Please visit the BioCapital Europe 2012 website at www.biocapitaleurope.com for online registration. If you require assistance, or have any questions, please do not hesitate to contact Jenna Parker on +44 (0) 20 7250 7043 or email her on wraan.cnexre@ivgrffrzrqvn.pb.hx
« back to overview